Cardiologist and JAMA Deputy Editor Greg Curfman, MD, discusses the many changes in the new AHA/ACC/HRS atrial fibrillation guidelines with University of Chicago cardiologists Gaurav Upadhyay, MD, and Francis Alenghat, MD, PhD. Major changes include recommendations for the use of various agents for anticoagulation, catheter ablation, and left atrial appendage occlusion.
Read the article: Management of Patients With Atrial Fibrillation)
Index of content:
2:19 Summary of the new ACC/AHA Atrial Fibrillation Guideline
8:04 Cost and efficacy of NOACs used to treat atrial fibrillation
11:42 Preference for specific NOACs
14:00 Rate vs rhythm control
20:00 How catheter ablation is performed
26:20 Anticoagulation requirements following ablation
31:23 How to achieve rate control
32:25 Left atrial appendage occlusion devices
36:29 New lifestyle recommendation
37:44 More about rate vs rhythm control
